Neuro-ophthalmology is a rapidly-evolving field of medicine combining expertise from both neurology and ophthalmology to diagnose and manage diseases of the eyes and optic nerve. By coordinating the efforts of both ophthalmologists and neurologists, neuro-ophthalmologists are able to provide optimal care for eye diseases that are best managed in an integrated approach. Clinical neuro-ophthalmology involves the diagnosis and management of patients with consideration of both ophthalmic and neurological symptoms and signs. These include headaches, visual disturbances like diplopia (double vision) or decreased vision, eye movement disturbances, pupillary abnormalities, eyelid disorders, orbital disorders, tumors, and oculomotor nerve palsies. In addition, neuro-ophthalmologists provide clinical diagnosis and management for optic neuropathies such as glaucoma and multiple sclerosis, aneurysms, and tumors or masses of the optic nerve. Basic neuro-ophthalmology involves research on topics such as visual system pathophysiology, electrophysiology, non-invasive imaging, molecular genetics, and clinical outcome research. These studies are necessary to gain a better understanding of visual anatomy, development of new diagnostic and therapeutic tools, and to gain exposure to new treatments and therapies. In addition, gene-therapy and pre-clinical research provide insight into tissue and cell responses to various treatment strategies. Ultimately, neuro-ophthalmology is both a clinical and a basic science, providing the foundation for recent advances in the diagnosis and management of eye diseases through advances in both neurology and ophthalmology. By combining knowledge from both specialties, neuro-ophthalmologists are able to provide optimal, coordinated care to patients with eye diseases.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom